✦ LIBER ✦

Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma

✍ Scribed by Donna M. Weber; Thorsten Graef; Mohamad Hussein; Ronald M. Sobecks; Gary J. Schiller; Lisa Lupinacci; James S. Hardwick; Sundar Jagannath

Book ID: 119219056
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 279 KB
Volume: 12
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II Trial Assessing Bortezomib an

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

✍ Berenson, J. R. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 103 KB

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

A573 Phase I Trial of CCI-779 and Weekly

A573 Phase I Trial of CCI-779 and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma

✍ Roccaro, AM; Leduc, R; Nelson, M; Sam, A; Chuma, S; Colson, K; O'Connor, K; Ghob 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Tanespimycin and bortezomib combination

Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study

✍ Paul G. Richardson; Asher A. Chanan-Khan; Sagar Lonial; Amrita Y. Krishnan; Mich 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

A phase I safety study of enzastaurin pl

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

✍ Irene M. Ghobrial; Nikhil C. Munshi; Brianna N. Harris; Peipei Shi; Nichole M. P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

A phase I study of bortezomib in combina

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB